313 related articles for article (PubMed ID: 24994866)
1. Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy.
Huang D; Luo Q; Yang H; Mao Y
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4935-43. PubMed ID: 24994866
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy.
Huang D; Xu N; Song Y; Wang P; Yang H
Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):619-25. PubMed ID: 22124787
[TBL] [Abstract][Full Text] [Related]
3. Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies.
Eckstein AK; Finkenrath A; Heiligenhaus A; Renzing-Köhler K; Esser J; Krüger C; Quadbeck B; Steuhl KP; Gieseler RK
Acta Ophthalmol Scand; 2004 Jun; 82(3 Pt 1):291-7. PubMed ID: 15115450
[TBL] [Abstract][Full Text] [Related]
4. Graves' orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines.
Ujhelyi B; Gogolak P; Erdei A; Nagy V; Balazs E; Rajnavolgyi E; Berta A; Nagy EV
Thyroid; 2012 Apr; 22(4):407-14. PubMed ID: 22385289
[TBL] [Abstract][Full Text] [Related]
5. Proteomics of tear fluid in thyroid-associated orbitopathy.
Matheis N; Okrojek R; Grus FH; Kahaly GJ
Thyroid; 2012 Oct; 22(10):1039-45. PubMed ID: 22873942
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of 99mTc-DTPA orbital SPECT/CT on the evaluation of lacrimal gland inflammation in patients with
thyroid associated ophthalmopathy].
Jiang C; Li X; Zhao M; Dend H; Huang J; Liu D; Xu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 44(3):322-328. PubMed ID: 30971526
[TBL] [Abstract][Full Text] [Related]
7. The Change of Lacrimal Gland Volume in Korean Patients with Thyroid-associated Ophthalmopathy.
Huh HD; Kim JH; Kim SJ; Yoo JM; Seo SW
Korean J Ophthalmol; 2016 Oct; 30(5):319-325. PubMed ID: 27729751
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging parameters on lacrimal gland in thyroid eye disease: a systematic review and meta-analysis.
Wong NTY; Yuen KFK; Aljufairi FMAA; Lai KKH; Hu Z; Chan KKW; Tham CCY; Pang CP; Chong KKL
BMC Ophthalmol; 2023 Aug; 23(1):347. PubMed ID: 37550660
[TBL] [Abstract][Full Text] [Related]
9. Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy.
Kishazi E; Dor M; Eperon S; Oberic A; Turck N; Hamedani M
Sci Rep; 2018 Jul; 8(1):10792. PubMed ID: 30018377
[TBL] [Abstract][Full Text] [Related]
10. Tear inflammatory cytokines and ocular surface changes in patients with active thyroid eye disease treated with high-dose intravenous glucocorticoids.
Xu N; Cui Y; Fu D; Sun F
J Endocrinol Invest; 2020 Jul; 43(7):901-910. PubMed ID: 31927748
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy.
Byun JS; Moon NJ; Lee JK
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):413-420. PubMed ID: 27838736
[TBL] [Abstract][Full Text] [Related]
12. Correlation between extent of lacrimal gland prolapse and clinical features of thyroid-associated ophthalmopathy: a retrospective observational study.
Gao Y; Chang Q; Li Y; Zhang H; Hou Z; Zhang Z; Li Z; Li D
BMC Ophthalmol; 2022 Feb; 22(1):66. PubMed ID: 35144579
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the levels of interleukin-17 and interleukin-38 in thyroid-associated ophthalmopathy patients.
Mussakulova A; Balmukhanova A; Aubakirova A; Zhunusova G; Balmukhanova A; Issakhanova J; Saliev T; Tanabayeva S; Fakhradiyev I
Int Ophthalmol; 2023 Aug; 43(8):2811-2824. PubMed ID: 36894821
[TBL] [Abstract][Full Text] [Related]
14. Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.
Shen J; Li Z; Li W; Ge Y; Xie M; Lv M; Fan Y; Chen Z; Zhao D; Han Y
Dis Markers; 2015; 2015():609593. PubMed ID: 26089587
[TBL] [Abstract][Full Text] [Related]
15. Proteomics Differentiate Between Thyroid-Associated Orbitopathy and Dry Eye Syndrome.
Matheis N; Grus FH; Breitenfeld M; Knych I; Funke S; Pitz S; Ponto KA; Pfeiffer N; Kahaly GJ
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2649-56. PubMed ID: 25829418
[TBL] [Abstract][Full Text] [Related]
16. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.
Lee SY; Han SJ; Nam SM; Yoon SC; Ahn JM; Kim TI; Kim EK; Seo KY
Am J Ophthalmol; 2013 Aug; 156(2):247-253.e1. PubMed ID: 23752063
[TBL] [Abstract][Full Text] [Related]
17. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.
Na KS; Mok JW; Kim JY; Rho CR; Joo CK
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5443-50. PubMed ID: 22789923
[TBL] [Abstract][Full Text] [Related]
18. Pirfenidone attenuates the IL-1β-induced hyaluronic acid increase in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
Chung SA; Jeon BK; Choi YH; Back KO; Lee JB; Kook KH
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2276-83. PubMed ID: 24627146
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotype of Lacrimal Glands in Graves Orbitopathy: Implications for the Pathogenesis of Th1 and Th17 Immunity.
Huang Y; Wu Y; Zhang S; Lu Y; Wang Y; Liu X; Zhong S; Wang Y; Li Y; Sun J; Fang S; Zhou H
Thyroid; 2022 Aug; 32(8):949-961. PubMed ID: 35469435
[No Abstract] [Full Text] [Related]
20. Lacrimal gland herniation in Graves ophthalmopathy: a simple and useful MRI biomarker of disease activity.
Gagliardo C; Radellini S; Morreale Bubella R; Falanga G; Richiusa P; Vadalà M; Ciresi A; Midiri M; Giordano C
Eur Radiol; 2020 Apr; 30(4):2138-2141. PubMed ID: 31953667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
